Newsfeeds - Spark Newswire

5 minute read

Liminal BioSciences Subsidiary, Prometic Biotherapeutics Inc., Sells Rare Pediatric Disease Priority Review Voucher For $105M

Today, 9:18 AM

Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that, its subsidiary Prometic Biotherapeutics Inc. ("PBT") has entered into a Liminal BioSciences Inc.

LMNL

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 9:18 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

8 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:18 AM

Monday morning saw 115 companies set new 52-week lows.

AGCB

4 minute read

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay

By Shanthi Rexaline

Today, 9:18 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)

ABCL

5 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 9:18 AM

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows.

ABCL

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

Today, 9:18 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

20 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:18 AM

Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.

AAU

5 minute read

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study

By Shanthi Rexaline

Today, 9:18 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)

ABCL

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 24, 2021

By Benzinga Insights

Today, 9:18 AM

ADI

2 minute read

Liminal BioSciences Announces Signature Of Share Purchase Agreement For Sale Of Remaining Plasma-Derived Business With Kedrion

By Benzinga Newsdesk

Today, 9:18 AM

Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), announced today that, Kedrion S.p.A ("Kedrion") has exercised its option to acquire the remainder of the

LMNL